<scp>Real‐World</scp> Treatment and Care Patterns in Patients With Rheumatoid Arthritis Initiating <scp>First‐Line</scp> Tumor Necrosis Factor Inhibitor Therapy in the United States

Colin Edgerton, Andrew Frick, Simon Helfgott, Kent Kwas Huston, Jasvinder A. Singh, Patrick Zueger, Samuel I. Anyanwu, Pankaj Patel, Nehad Soloman

Open source

DOI
10.1002/acr2.11646
Published
2024-01-14
Container
ACR Open Rheumatology
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/acr2.11646,
  title = {<scp>Real‐World</scp>
                    Treatment and Care Patterns in Patients With Rheumatoid Arthritis Initiating
                    <scp>First‐Line</scp>
                    Tumor Necrosis Factor Inhibitor Therapy in the United States},
  author = {Colin Edgerton and Andrew Frick and Simon Helfgott and Kent Kwas Huston and Jasvinder A. Singh and Patrick Zueger and Samuel I. Anyanwu and Pankaj Patel and Nehad Soloman},
  year = {2024},
  journal = {ACR Open Rheumatology},
  doi = {10.1002/acr2.11646},
  url = {https://doi.org/10.1002/acr2.11646}
}

RIS

TY  - JOUR
TI  - <scp>Real‐World</scp>
                    Treatment and Care Patterns in Patients With Rheumatoid Arthritis Initiating
                    <scp>First‐Line</scp>
                    Tumor Necrosis Factor Inhibitor Therapy in the United States
AU  - Colin Edgerton
AU  - Andrew Frick
AU  - Simon Helfgott
AU  - Kent Kwas Huston
AU  - Jasvinder A. Singh
AU  - Patrick Zueger
AU  - Samuel I. Anyanwu
AU  - Pankaj Patel
AU  - Nehad Soloman
PY  - 2024
JO  - ACR Open Rheumatology
DO  - 10.1002/acr2.11646
UR  - https://doi.org/10.1002/acr2.11646
ER  - 

APA

Edgerton, C., Frick, A., Helfgott, S., Huston, K. K., Singh, J. A., Zueger, P., Anyanwu, S. I., Patel, P., & Soloman, N. (2024). <scp>Real‐World</scp> Treatment and Care Patterns in Patients With Rheumatoid Arthritis Initiating <scp>First‐Line</scp> Tumor Necrosis Factor Inhibitor Therapy in the United States. ACR Open Rheumatology. https://doi.org/10.1002/acr2.11646

Source records